You are here: Home » PTI Stories » National » News
Business Standard

Bayer CropScience Q2 net profit sees marginal rise at Rs 159cr

Press Trust of India  |  New Delhi 

Ltd today reported a marginal increase of 2 per cent in net profit at Rs 159.1 crore for the quarter ended September 30, on higher sales.

Its net profit stood at Rs 155.8 crore in the year-ago period, the company said in a regulatory filing.



Income from operations rose to Rs 1,160 crore during July-September quarter of this fiscal from Rs 1,055.2 crore in the corresponding period of the previous fiscal.

Bayer is a global enterprise with core competencies in the life science fields of healthcare and agriculture. In India, is into seed and crop protection business.

Last month, the German pharmaceutical and chemical giant Bayer AG announced it will acquire global seed major Monsanto for USD 66 billion in an all-cash deal.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Bayer CropScience Q2 net profit sees marginal rise at Rs 159cr

Bayer CropScience Ltd today reported a marginal increase of 2 per cent in net profit at Rs 159.1 crore for the quarter ended September 30, on higher sales. Its net profit stood at Rs 155.8 crore in the year-ago period, the company said in a regulatory filing. Income from operations rose to Rs 1,160 crore during July-September quarter of this fiscal from Rs 1,055.2 crore in the corresponding period of the previous fiscal. Bayer is a global enterprise with core competencies in the life science fields of healthcare and agriculture. In India, Bayer CropScience is into seed and crop protection business. Last month, the German pharmaceutical and chemical giant Bayer AG announced it will acquire global seed major Monsanto for USD 66 billion in an all-cash deal. Ltd today reported a marginal increase of 2 per cent in net profit at Rs 159.1 crore for the quarter ended September 30, on higher sales.

Its net profit stood at Rs 155.8 crore in the year-ago period, the company said in a regulatory filing.

Income from operations rose to Rs 1,160 crore during July-September quarter of this fiscal from Rs 1,055.2 crore in the corresponding period of the previous fiscal.

Bayer is a global enterprise with core competencies in the life science fields of healthcare and agriculture. In India, is into seed and crop protection business.

Last month, the German pharmaceutical and chemical giant Bayer AG announced it will acquire global seed major Monsanto for USD 66 billion in an all-cash deal.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Bayer CropScience Q2 net profit sees marginal rise at Rs 159cr

Ltd today reported a marginal increase of 2 per cent in net profit at Rs 159.1 crore for the quarter ended September 30, on higher sales.

Its net profit stood at Rs 155.8 crore in the year-ago period, the company said in a regulatory filing.

Income from operations rose to Rs 1,160 crore during July-September quarter of this fiscal from Rs 1,055.2 crore in the corresponding period of the previous fiscal.

Bayer is a global enterprise with core competencies in the life science fields of healthcare and agriculture. In India, is into seed and crop protection business.

Last month, the German pharmaceutical and chemical giant Bayer AG announced it will acquire global seed major Monsanto for USD 66 billion in an all-cash deal.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22